EPIDIOLEX

Curated by Signal

Developer of cannabinoid therapeutics for the nervous system

Overview

Developer of cannabinoid therapeutics for the nervous system. The drug Epidiolex is used to treat seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in children under 1 year of age.

Key facts

Founded: 2013
Headquarters: Salisbury, United Kingdom
Stage: Sign up to view
Industry: Health Technology

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

AzurianHealth
Remote health monitoring platform for providers to measure the vital signs of patients
Health TechnologyLondon, United Kingdom
HappierMe
Provider of mindfulness application for mental health management
Health TechnologyYarm, United Kingdom
FIT BREED
App for finding fitness trainers for online training
Health TechnologyLondon, United Kingdom

About EPIDIOLEX

What does EPIDIOLEX do?

Developer of cannabinoid therapeutics for the nervous system.

Where is EPIDIOLEX headquartered?

EPIDIOLEX is headquartered in Salisbury, United Kingdom.

When was EPIDIOLEX founded?

EPIDIOLEX was founded in 2013.

Which sector is EPIDIOLEX in?

EPIDIOLEX operates in Health Technology.

Who are EPIDIOLEX's competitors?

Companies similar to EPIDIOLEX include AzurianHealth, HappierMe, and FIT BREED.